Joint Formulary & PAD

Potassium Permanganate Concentrate (tablets for cutaneous solution) - Wound management

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Tablets for cutaneous solution
Associated Icons :
Restrictions / Comments :
Important

DO NOT add to repeat prescription and ensure patient/carer is aware of need  to dilute before use and harmful if swallowed.
Use in Primary Care - only on recommendation from dermatology or tissue viability nurse.

For EXTERNAL USE ONLY

Potassium permanganate is routinely used in the NHS as a dilute solution to treat weeping and blistering skin conditions, such as acute weeping/ infected eczema and leg ulcers.
Supplied in concentrated forms, either as a ‘tablet’ or a solution, it requires dilution before it is used as a soak or in the bath. These concentrated forms resemble an oral tablet or juice drink and if ingested are highly toxic.
If potassium permanganate is to be used in a patient’s home, a risk assessment must be undertaken before prescribing
The form below has been agreed by MSC and can be used for the risk assessment for patients.

Documentation

PAD Profile

ChemicalSubstance :
Potassium Permanganate Concentrate (tablets for cutaneous solution)
Indication :
Wound management
Group Name :
Keywords :
potassium solution, potassium baths, potassium wet dressings, potassium soak, skin cleansing
Brand Names Include :
Permitabs, EN-Potab
Important Information :

For EXTERNAL USE only.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Potassium Permanganate Concentrate (tablets for cutaneous solution) is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Wound management.

Committee Recommendations (1)

For EXTERNAL USE ONLY

Potassium permanganate is routinely used in the NHS as a dilute solution to treat weeping and blistering skin conditions, such as acute weeping/ infected eczema and leg ulcers.
Supplied in concentrated forms, either as a ‘tablet’ or a solution, it requires dilution before it is used as a soak or in the bath. These concentrated forms resemble an oral tablet or juice drink and if ingested are highly toxic.
If potassium permanganate is to be used in a patient’s home, a risk assessment must be undertaken before prescribing
The form below has been agreed by MSC and can be used for the risk assessment for patients.